Pubblicazioni

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia

2016 - EUROPEAN JOURNAL OF HAEMATOLOGY

Voso, Maria Teresa; Niscola, Pasquale; Piciocchi, Alfonso; Fianchi, Luana; Maurillo, Luca; Musto, Pellegrino; Pagano, Livio; Mansueto, Giovanna; Criscuolo, Marianna; ALOE SPIRITI, Maria Antonietta; Buccisano, Francesco; Venditti, Adriano; Tendas, Andrea; Piccioni, Anna Lina; Zini, Gina; Latagliata, Roberto; Filardi, Nunzio; Fragasso, Alberto; Fenu, Susanna; Breccia, Massimo